| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Alendronate | FAERS: 11 | US FAERS | |
| 2 | Anastrozole | FAERS: 1 | US FAERS | |
| 3 | Aspirin-oxycodone hydrochloride-oxycodone terephthalate combination | FAERS: 1 | US FAERS | |
| 4 | Fosamax plus D | FAERS: 1 | US FAERS | |
| 5 | Lansoprazole | FAERS: 1 | US FAERS | |
| 6 | Methylphenidate | FAERS: 1 | US FAERS | |
| 7 | Pregabalin | FAERS: 1 | US FAERS | |
| 8 | Rosuvastatin Calcium | FAERS: 1 | US FAERS | |
| 9 | Zoledronic Acid | FAERS: 1 | US FAERS | |
| 10 | adefovir dipivoxil | FAERS: 1 | US FAERS | |
| 11 | lanreotide | FAERS: 1 | US FAERS | |
| 12 | Ifosfamide | OFFSIDES | ||
| 13 | Risperidone | SIDER |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.